Literature DB >> 11106212

Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease.

T A Seemungal1, R Harper-Owen, A Bhowmik, D J Jeffries, J A Wedzicha.   

Abstract

Common colds are associated with exacerbations of chronic obstructive pulmonary disease (COPD). However, the role of the common cold virus (human rhinovirus) in the production of symptoms and lower airway inflammation at COPD exacerbation is unknown. Thirty three patients with moderate-to-severe COPD were seen at baseline, when the number of chest infections in the previous year was noted, and acutely at COPD exacerbation. Within 48 h after the onset of the exacerbation and at baseline, nasal aspirates and induced sputum were taken for rhinovirus reverse transcriptase polymerase chain reaction (RT-PCR) analysis and determination of cytokine levels. Symptoms, recorded on diary cards, were noted and forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) measured. At exacerbation, mean FEV1 and FVC fell significantly from baseline (p<0.001). Ten of 43 exacerbations were associated with rhinovirus infection, detected in induced sputum. In four of these, nasopharyngeal samples contained no detectable rhinovirus. All baseline samples were negative for rhinovirus. The simultaneous presence of increased nasal discharge/nasal congestion (in 26 of the 43 exacerbations) and increased sputum (29 exacerbations) was strongly associated with the presence of rhinovirus (odds ratio 6.15; p=0.036). Total symptom scores were greater for rhinovirus as compared to nonrhinovirus exacerbations (p=0.039). Median baseline sputum interleukin-6 levels rose from 90.2 to 140.3 pg x mL(-1) at exacerbation (p=0.005); the change was greater in the presence of rhinovirus infection (p=0.008). Rhinovirus infection can be detected at chronic obstructive pulmonary disease exacerbation. This is associated with elevation of lower airway interleukin-6 levels, which may mediate lower airway symptom expression during chronic obstructive pulmonary disease exacerbations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106212      PMCID: PMC7163563          DOI: 10.1034/j.1399-3003.2000.16d19.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  103 in total

Review 1.  Management of an acute exacerbation of copd: are we ignoring the evidence?

Authors:  M K Johnson; R D Stevenson
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

Review 2.  The influence of virus infections on the course of COPD.

Authors:  H Frickmann; S Jungblut; T O Hirche; U Groß; M Kuhns; A E Zautner
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

Review 3.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

4.  The Anti-inflammatory Effect of Alpha-1 Antitrypsin in Rhinovirus-infected Human Airway Epithelial Cells.

Authors:  Di Jiang; Reena Berman; Qun Wu; Connor Stevenson; Hong Wei Chu
Journal:  J Clin Cell Immunol       Date:  2016-12-05

5.  Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease.

Authors:  Gavin C Donaldson; Martin Law; Beverly Kowlessar; Richa Singh; Simon E Brill; James P Allinson; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2015-10-15       Impact factor: 21.405

Review 6.  Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease.

Authors:  Neil MacIntyre; Yuh Chin Huang
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

7.  Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.

Authors:  I S Patel; T A R Seemungal; M Wilks; S J Lloyd-Owen; G C Donaldson; J A Wedzicha
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

8.  Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD.

Authors:  Jennifer K Quint; Gavin C Donaldson; James J P Goldring; Ramin Baghai-Ravary; John R Hurst; Jadwiga A Wedzicha
Journal:  Chest       Date:  2009-10-16       Impact factor: 9.410

9.  Viral respiratory infection and the link to asthma.

Authors:  James E Gern
Journal:  Pediatr Infect Dis J       Date:  2008-10       Impact factor: 2.129

Review 10.  Strategies for improving outcomes of COPD exacerbations.

Authors:  Tom Wilkinson; J A Wedzicha
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.